November 2015 - OncoMasTR in Business&Finance

OncoMark profiled in 'Ones to Watch' article in Business & Finance

The Business & Finance magazine interviewed OncoMark's CEO, Mr Desmond O'Leary, to discuss the development of the OncoMasTR assay for early stage breast cancer.

The need for the OncoMasTR assay to determine which patients require chemotherapy was discussed, along with the funding awarded to OncoMark by the European Commission for product development. OncoMark, a Dublin-based company, plan to expand over the next two-three years, as the product development progresses. The OncoMasTR assay is expected to be available for clinical use in the next three years. 

The article can be viewed here: